Fast Track and Orphan Drug Designation for PXL065 and PXL770 in adrenoleukodystrophy (ALD) granted by the Food and Drug Administration (FDA) Phase 2 study results for PXL065 (DESTINY-1) in NASH expected in Q3 2022 As of March 31, 2022, cash and cash equivalents were EUR 24.0 million (USD 26.7 million) LYON, France–(BUSINESS WIRE)–POXEL SA (Euronext … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Head and Neck Cancer Therapeutics Market, By Type (Diagnostic Methods v/s Treatment Type), By Treatment Type (By Disease Indication, By Route of Administration, By Therapeutic Class), By End User, By Region, Company, Opportunities and Forecast, 2027” report has been added to ResearchAndMarkets.com’s offering. The Global Head and Neck Cancer Therapeutics Market value … [Read more…]
WASHINGTON–(BUSINESS WIRE)–The College of American Pathologists (CAP) President Emily E. Volk, MD, FCAP, released the following statement on the Health Equity and Accountability Act: “The College of American Pathologists applauds the introduction of the Health Equity and Accountability Act, which, among other things, includes policies to mitigate and eliminate the impact of social determinants of … [Read more…]
IRVINE, Calif.–(BUSINESS WIRE)–#biogennix–Irvine-based Biogennix, a market leader in advanced bone regeneration technology, announced today that its DirectCell Advanced Bone Grafting System has already been used in over 500 cases. Biogennix’s team of bone regeneration experts specifically designed this system to provide surgeons and hospitals with a comprehensive bone graft solution in a single product. The … [Read more…]
ORANGE, Calif.–(BUSINESS WIRE)–Western Dental & Orthodontics, one of the nation’s leaders in accessible, affordable oral health care and orthodontics, today announced the opening of three new California offices in Selma, San Lorenzo and the North Park area of San Diego. Western Dental has opened five new offices in 2022, expanding its network to 356 locations … [Read more…]
IRVING, Texas–(BUSINESS WIRE)–The End Drug Shortages Alliance today announced it has released a market analysis of products affected by a recent Teva pharmaceutical manufacturing plant closure in Irvine, Calif. The closure is expected to potentially impact approximately 25 pharmaceutical injectables that were manufactured at the plant, including five essential medications where Teva supplied greater than … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Aging Population and Medical Devices – Thematic Research” report has been added to ResearchAndMarkets.com’s offering. We are in the midst of a profound demographic shift as increases in life expectancy – coupled with declines in fertility – have substantially shifted population demographics. According to the United Nations, individuals aged 60 and over will … [Read more…]
LYON, France–(BUSINESS WIRE)–POXEL SA (Euronext: POXEL – FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare metabolic disorders, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to PXL065 and PXL770 for the … [Read more…]
GUILFORD, Conn.–(BUSINESS WIRE)–May 17, 2022–Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing single molecule protein sequencing, today announced that it will be participating in the Next-Generation Protein Analysis and Detection Conference, a VIB Tools & Technologies conference, taking place in Ghent, Belgium on May 30-31, 2022. Brian Reed, Ph.D., … [Read more…]
PRINCETON, N.J. & BANGALORE, India–(BUSINESS WIRE)–#CSR—MSITEK, a global provider of SAP technology-enabled business solutions, recently collaborated with Ganga Prem Hospice, a Hospice care organization that provides medical, spiritual, and emotional support to terminally ill cancer patients. MSITEK has taken up this initiative as part of its focus on Corporate Social Responsibility. They are investing in … [Read more…]
